Clinical Trial Update: The Prognostic Role of TILs and CD8+ T Cells in Operable Breast Cancer

View source ↗

Summary

A completed clinical trial evaluating the prognostic significance of tumor-infiltrating lymphocytes and CD8+ T cells in operable breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Hellenic Cooperative Oncology Group | Conditions: Early Breast Cancer | Status: COMPLETED